Galician Experience with Avatrombopag: Galician Thrombosis and Hemostasis Group

Avatrombopag, an orally administered 2nd-generation thrombopoietin receptor agonist (TPO-RA), in Spain is indicated for the treatment of primary chronic (>12 months) immune thrombocytopenia (ITP) in adults with inadecuate response or intolerance to other therapies, and has been the first agonist...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.5446-5446
Hauptverfasser:	Calvino-Suarez, Michael, Lopez Ansoar, Elsa, Lorenzo Vizcaya, Alvaro, Guzman Fernandez, Maria Rebeca, Dorado Lopez, Andrea, Salido Toimil, Fatima, Rodriguez Ruiz, Matilde, Iglesias Varela, Raquel, Vasco Varela, Beatriz, Blanquer Blanquer, Miguel, Rodriguez Lopez, Manuel
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!